Finance
Markets

TMO

stock NYSE
Thermo Fisher Scientific Inc.
$449.37 -2.42 (-0.54%) At close

Key stats

The day open and close within the day's range
Low $441.12 High $451.71
Open
$450.90
-0.20%
Close
$449.37
-0.54%
52-week range where the price sits across its year
52w low $385.46 52w high $643.99
Current
$449.37
Prev close
$451.79
Volume 0.95× the 3-month average
0 avg 2× avg
Today
2.01M
3-mo avg
2.13M

Fundamentals

Each ratio reads FY2025 figures against the latest price, graded so the quality shows at a glance.

P/E ratio Fair
25.3x

At 25x, investors are paying up; a fair amount of future growth is already in the price.

Share price divided by earnings per share: what you pay for each $1 of yearly profit. Roughly 15 to 25 is typical, above 40 is richly priced, and negative means the company is losing money.

Dividend yield Fair
0.38%

A 0.4% yield is modest: a small income on top of whatever the share price does.

The yearly dividend as a percent of the share price: the cash income each share pays out. Around 2 to 6% is healthy; above roughly 8% often signals the payout may be cut.

Profit margin Strong
15.0%

A 15.0% margin is strong; the company keeps a healthy slice of every revenue dollar.

The share of revenue left as profit once every cost is paid. Above 15% is strong; below 5% leaves little cushion against a bad year.

Return on equity Fair
12.6%

A 12.6% return on equity is respectable, in the normal range.

Profit earned on each dollar of shareholder equity: how well the company compounds its owners' capital. Above 15% is strong.

Return on assets Fair
6.1%

A 6.1% return on assets is reasonable for a company of this kind.

Profit earned on each dollar of assets: how efficiently the whole asset base is used. Above 8% is strong.

Debt-to-equity No data
·

Not enough data to compute debt-to-equity.

Total liabilities divided by shareholder equity: how heavily the company leans on borrowing. Below 1 is conservative; above 2 is highly leveraged.

Current ratio Strong
1.89

At 1.89, short-term assets comfortably cover short-term bills.

Current assets divided by current liabilities: whether short-term resources cover short-term bills. Above 1.5 is comfortable; below 1 is tight.

Revenue growth Fair
+3.9%

Revenue grew 3.9% from the prior year: steady, modest expansion.

Change in annual revenue from the prior fiscal year: whether the top line is expanding. Above 10% is strong growth; below 0 means revenue is shrinking.

Earnings growth Fair
+5.8%

Net income grew 5.8% from the prior year: steady profit expansion.

Change in annual net income from the prior fiscal year: whether profit is expanding. Above 10% is strong; below 0 means profit is falling.

Financials

FY2021FY2022FY2023FY2024FY2025
Revenue $39.2B$44.9B$42.9B$42.9B$44.6B
Net income $7.7B$7.0B$6.0B$6.3B$6.7B
Diluted EPS $19.46$17.63$15.45$16.53$17.74
Dividend / share $1.04$1.20$1.40$1.56$1.72
Total assets $95.1B$97.2B$98.7B$97.3B$110.3B
Total liabilities ·····
Shareholder equity $40.9B$44.0B$46.7B$49.6B$53.4B

Recent SEC filings